These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31719679)

  • 1. Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells.
    Riegel C; Boeld TJ; Doser K; Huber E; Hoffmann P; Edinger M
    Leukemia; 2020 Mar; 34(3):895-908. PubMed ID: 31719679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD.
    Ermann J; Hoffmann P; Edinger M; Dutt S; Blankenberg FG; Higgins JP; Negrin RS; Fathman CG; Strober S
    Blood; 2005 Mar; 105(5):2220-6. PubMed ID: 15546950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
    Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive Transfer of Treg Cells Combined with Mesenchymal Stem Cells Facilitates Repopulation of Endogenous Treg Cells in a Murine Acute GVHD Model.
    Lee ES; Lim JY; Im KI; Kim N; Nam YS; Jeon YW; Cho SG
    PLoS One; 2015; 10(9):e0138846. PubMed ID: 26393514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.
    Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX
    Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease
    Liu H; Yu Z; Tang B; Miao S; Qin C; Li Y; Liang Z; Shi Y; Zhang Y; Wang Q; Yan M; Song Z; Ren H; Dong Y
    Front Immunol; 2021; 12():647894. PubMed ID: 34262560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
    Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
    J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-L1 Ameliorates Murine Acute Graft-Versus-Host Disease by Suppressing Effector But Not Regulatory T Cells Function.
    Tang L; Ma S; Gong H; Wang J; Xu Y; Wu D; Sun A
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):179-187. PubMed ID: 30927016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIAS3 suppresses acute graft-versus-host disease by modulating effector T and B cell subsets through inhibition of STAT3 activation.
    Lee SH; Moon SJ; Park MJ; Kim EK; Moon YM; Cho ML
    Immunol Lett; 2014 Jul; 160(1):79-88. PubMed ID: 24718277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third-party regulatory T cells prevent murine acute graft-versus-host disease.
    Lim JY; Im KI; Song Y; Kim N; Nam YS; Jeon YW; Cho SG
    Korean J Intern Med; 2018 Sep; 33(5):980-989. PubMed ID: 29050459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recipient myeloid-derived immunomodulatory cells induce PD-1 ligand-dependent donor CD4+Foxp3+ regulatory T cell proliferation and donor-recipient immune tolerance after murine nonmyeloablative bone marrow transplantation.
    van der Merwe M; Abdelsamed HA; Seth A; Ong T; Vogel P; Pillai AB
    J Immunol; 2013 Dec; 191(11):5764-76. PubMed ID: 24190658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation.
    Su X; Wang Q; Guo W; Pei X; Niu Q; Liu M; Liu Y; Chen S; Feng S; He Y; Yang D; Zhang R; Ma Q; Zhai W; Pang A; Wei J; Huang Y; Luo Y; Han M; Feng X; Jiang E
    Cell Mol Immunol; 2020 May; 17(5):483-495. PubMed ID: 31664223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
    Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
    Front Immunol; 2018; 9():3104. PubMed ID: 30733722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice.
    Daenthanasanmak A; Iamsawat S; Chakraborty P; Nguyen HD; Bastian D; Liu C; Mehrotra S; Yu XZ
    Blood; 2019 Jan; 133(3):266-279. PubMed ID: 30514750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of Graft-Versus-Host Disease Control Efficacy by Adoptive Transfer of Type 1 Regulatory T Cells in Bone Marrow Transplant Model.
    Jeon YW; Lim JY; Im KI; Kim N; Nam YS; Song YJ; Cho SG
    Stem Cells Dev; 2019 Jan; 28(2):129-140. PubMed ID: 30381994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells contribute to the immunoregulatory effect on graft versus host reaction after liver transplantation in donor-dominant one-way MHC matching rats.
    Xue F; Chen W; Wang X; Wang L; Xu G; Liang L; Bai X; Liang T
    Transpl Immunol; 2009 Mar; 20(4):232-7. PubMed ID: 19041396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
    Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
    Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
    Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.
    Li Y; Chen HL; Bannick N; Henry M; Holm AN; Metwali A; Urban JF; Rothman PB; Weiner GJ; Blazar BR; Elliott DE; Ince MN
    J Immunol; 2015 Feb; 194(3):1011-20. PubMed ID: 25527786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.